Woodford Invt. Management sells down stake in Reckitt Benckiser
In its monthly update fund manager Woodford Investment Management has informed that in September it unwound its position in shares of Reckitt Benckiser completely.
AstraZeneca
9,990.00p
15:45 15/11/24
-2.93%
-302.00p
FTSE 100
8,060.61
15:45 15/11/24
n/a
n/a
G4S
244.80p
16:40 04/05/21
-0.20%
-0.50p
Imperial Brands
2,370.00p
15:45 15/11/24
0.77%
18.00p
Reckitt Benckiser Group
4,756.00p
15:45 15/11/24
0.55%
26.00p
The fund manager did however add to its positions in G4S and Imperial Tobacco, it said, while making positive comments on the "significant long-term potential" that is building in AstraZeneca's clinical pipeline.